Decision of the EEA Joint Committee No 93/2025 of 8 May 2025 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2025/1380]
Date: 2025-05-08
Institutions: EEA Joint Committee
Subjects: European Economic Area, dangerous substance, market approval, plant health control, plant health product, revision of an agreement, withdrawal from the market




L_202501380EN.000101.fmx.xml












Official Journal of the European Union


EN
L series













2025/1380


24.7.2025







            DECISION OF THE EEA JOINT COMMITTEE No 93/2025
of 8 May 2025
         
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2025/1380]


THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:







(1)


Commission Implementing Regulation (EU) 2024/2766 of 30 October 2024 concerning the non-approval of 1,3,7-trimethylxanthine (caffeine) as a basic substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (1) is to be incorporated into the EEA Agreement.












(2)


Commission Implementing Regulation (EU) 2024/2777 of 31 October 2024 concerning the non-renewal of approval of the active substance tritosulfuron, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (2) is to be incorporated into the EEA Agreement.












(3)


Commission Implementing Regulation (EU) 2024/2781 of 31 October 2024 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 8-hydroxyquinoline, aminopyralid, azoxystrobin, Candida oleophila strain O, chlorantraniliprole, fluroxypyr, imazalil, kresoxim-methyl, metobromuron, oxyfluorfen, Paecilomyces fumosoroseus strain FE 9901, tefluthrin and terbuthylazine (3) is to be incorporated into the EEA Agreement.












(4)


Commission Implementing Regulation (EU) 2024/2806 of 31 October 2024 concerning the non-renewal of the approval of the active substance metribuzin, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 and Commission Implementing Regulation (EU) 2015/408 (4) is to be incorporated into the EEA Agreement.












(5)


Annex II to the EEA Agreement should therefore be amended accordingly,





HAS ADOPTED THIS DECISION:



Article 1
Chapter XV of Annex II to the EEA Agreement shall be amended as follows:






1.


The following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011):






‘—



32024 R 2777: Commission Implementing Regulation (EU) 2024/2777 of 31 October 2024 (OJ L, 2024/2777, 4.11.2024),










—



32024 R 2781: Commission Implementing Regulation (EU) 2024/2781 of 31 October 2024 (OJ L, 2024/2781, 4.11.2024),










—



32024 R 2806: Commission Implementing Regulation (EU) 2024/2806 of 31 October 2024 (OJ L, 2024/2806, 4.11.2024).’














2.


The following indent is added in point 13zzzzt (Commission Implementing Regulation (EU) 2015/408):






‘—



32024 R 2806: Commission Implementing Regulation (EU) 2024/2806 of 31 October 2024 (OJ L, 2024/2806, 4.11.2024).’














3.


The following points are inserted after point 13zzzzzzzzzzzzzzx (Commission Implementing Regulation (EU) 2024/2390):






‘13zzzzzzzzzzzzzzy.



32024 R 2766: Commission Implementing Regulation (EU) 2024/2766 of 30 October 2024 concerning the non-approval of 1,3,7-trimethylxanthine (caffeine) as a basic substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (OJ L, 2024/2766, 31.10.2024).










13zzzzzzzzzzzzzzz.



32024 R 2777: Commission Implementing Regulation (EU) 2024/2777 of 31 October 2024 concerning the non-renewal of approval of the active substance tritosulfuron, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L, 2024/2777, 4.11.2024).










13zzzzzzzzzzzzzzza.



32024 R 2806: Commission Implementing Regulation (EU) 2024/2806 of 31 October 2024 concerning the non-renewal of the approval of the active substance metribuzin, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 and Commission Implementing Regulation (EU) 2015/408 (OJ L, 2024/2806, 4.11.2024).’










Article 2
The texts of Implementing Regulations (EU) 2024/2766, (EU) 2024/2777, (EU) 2024/2781 and (EU) 2024/2806 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.


Article 3
This Decision shall enter into force on 9 May 2025, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).


Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.




Done at Brussels, 8 May 2025.


For the EEA Joint Committee


The President

Nicolas VON LINGEN
            





(1)  
            OJ L, 2024/2766, 31.10.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/2766/oj.

(2)  
            OJ L, 2024/2777, 4.11.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/2777/oj.

(3)  
            OJ L, 2024/2781, 4.11.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/2781/oj.

(4)  
            OJ L, 2024/2806, 4.11.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/2806/oj.

(*1)  No constitutional requirements indicated.


ELI: http://data.europa.eu/eli/dec/2025/1380/oj
ISSN 1977-0677 (electronic edition)